About Zelluna Immunotherapy
Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable.
Facts about Zelluna Immunotherapy
Facts about Zelluna Immunotherapy
- Focus : Manufacturer
- Industry : Biotechnology
